These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 19295284)
1. [A case of PEP(BEP)-resistant ovarian dysgerminoma successfully treated by VeIP therapy]. Ishibashi M; Nakayama K; Oride A; Yeasmin S; Katagiri A; Iida K; Nakayama N; Miyazaki K Gan To Kagaku Ryoho; 2009 Mar; 36(3):513-7. PubMed ID: 19295284 [TBL] [Abstract][Full Text] [Related]
2. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89]. Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864 [TBL] [Abstract][Full Text] [Related]
3. Late recurrence in ovarian dysgerminoma with successful response to standard adjuvant chemotherapy: a case report and review of the literature. Jeyakumar A; Cabeza R; Hindenburg A Gynecol Oncol; 2001 May; 81(2):314-7. PubMed ID: 11330968 [TBL] [Abstract][Full Text] [Related]
4. Ovarian dysgerminoma with massive metastases to para-aortic lymph nodes. Takemori M; Ichimura T; Nishimura R; Hasegawa K Gynecol Obstet Invest; 2000; 49(3):211-3. PubMed ID: 10729765 [TBL] [Abstract][Full Text] [Related]
5. [Paclitaxel + carboplatin (TC)-resistant stage Ic squamous cell carcinomas arising in mature cystic teratomas of the ovary]. Ishikawa M; Nakayama K; Yeasmin S; Katagiri A; Iida K; Nakayama N; Miyazaki K Gan To Kagaku Ryoho; 2010 Apr; 37(4):747-52. PubMed ID: 20414041 [TBL] [Abstract][Full Text] [Related]
6. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. Brewer M; Gershenson DM; Herzog CE; Mitchell MF; Silva EG; Wharton JT J Clin Oncol; 1999 Sep; 17(9):2670-75. PubMed ID: 10561340 [TBL] [Abstract][Full Text] [Related]
7. [Adjuvant chemotherapy in dysgerminoma]. Fechtig A; de Dycker RP; Schumacher T; Neumann RL Geburtshilfe Frauenheilkd; 1991 May; 51(5):398-400. PubMed ID: 1869011 [TBL] [Abstract][Full Text] [Related]
8. A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice. Newton C; Murali K; Ahmad A; Hockings H; Graham R; Liberale V; Sarker SJ; Ledermann J; Berney DM; Shamash J; Banerjee S; Stoneham S; Lockley M Eur J Cancer; 2019 May; 113():19-27. PubMed ID: 30954883 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study]. Göbel U; Bamberg M; Engert J; Gnekow AK; Haas HJ; Jürgens H; Kühl J; Lenard HG; Lumenta C; Niethammer D Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267 [TBL] [Abstract][Full Text] [Related]
10. Complete response to paclitaxel, ifosfamide, and cisplatin therapy in a case of ovarian ependymoma. Hino M; Kobayashi Y; Wada M; Hattori Y; Kurahasi T; Nakagawa H J Obstet Gynaecol Res; 2016 Nov; 42(11):1613-1617. PubMed ID: 27785897 [TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group. Williams SD; Blessing JA; Hatch KD; Homesley HD J Clin Oncol; 1991 Nov; 9(11):1950-5. PubMed ID: 1719142 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group. Williams SD; Kauderer J; Burnett AF; Lentz SS; Aghajanian C; Armstrong DK Gynecol Oncol; 2004 Dec; 95(3):496-9. PubMed ID: 15581952 [TBL] [Abstract][Full Text] [Related]
13. PVB chemotherapy in patients with recurrent or advanced dysgerminoma: a Phase II study of the EORTC Gynaecological Cancer Cooperative Group. Pawinski A; Favalli G; Ploch E; Sahmoud T; van Oosterom AT; Pecorelli S Clin Oncol (R Coll Radiol); 1998; 10(5):301-5. PubMed ID: 9848330 [TBL] [Abstract][Full Text] [Related]
14. Para-aortic lymph node metastasis in malignant dysgerminoma of the ovary. Kasenda B; Harter P; Hirsch T; Ast A; Buhrmann C; Glaser F; Du Bois A Acta Obstet Gynecol Scand; 2009; 88(11):1288-90. PubMed ID: 19900144 [TBL] [Abstract][Full Text] [Related]
15. Treatment of recurrent and persistent germ cell tumors with cisplatin, vinblastine, and bleomycin. Jacobs AJ; Harris M; Deppe G; DasGupta I; Cohen CJ Obstet Gynecol; 1982 Jan; 59(1):129-32. PubMed ID: 6176923 [TBL] [Abstract][Full Text] [Related]
16. [Characteristics of rare ovarian tumors--possibilities of organ preservation]. Grischke EM; Wallwiener D; Bastert G Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007 [TBL] [Abstract][Full Text] [Related]
17. Ovarian dysgerminoma associated with fibrosarcoma: a case report. Alvarado-Cabrero I; Valencia-Cedillo R; Mohs-Alfaro M; De Anda-González J Int J Gynecol Pathol; 2011 Sep; 30(5):466-9. PubMed ID: 21804387 [TBL] [Abstract][Full Text] [Related]
18. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia]. Song SQ; Zhang GN Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapy of ovarian germ cell tumors. Williams SD Hematol Oncol Clin North Am; 1991 Dec; 5(6):1261-9. PubMed ID: 1663943 [TBL] [Abstract][Full Text] [Related]
20. Recent management of malignant ovarian germ cell tumors: a study of 34 cases. Linasmita V; Srisupundit S; Wilailak S; Tangtrakul S; Israngura N; Bullangpoti S J Obstet Gynaecol Res; 1999 Oct; 25(5):315-20. PubMed ID: 10533325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]